IL1A and HIV-1 infection: In contrast, the apparent dichotomous observation of greatly increased barrier dysfunction and leakage along with decreased TNF-α and IL-1α production after treatment with MPA and HIV-1 challenge indicate that MPA may still lead to enhanced HIV-1 infection due to increased viral entry.